ARTICLE | Clinical News
Catioprost: Phase II started
January 3, 2011 8:00 AM UTC
Novagali began a single-blind, U.S Phase II trial to compare Catioprost vs. Travatan Z travoprost in 100 patients with glaucoma or ocular hypertension and ocular surface disease. Alcon Inc. (NYSE:AC...